Adda Grimberg

Senior Fellow

Adda Grimberg, MD

  • Professor, Pediatrics, Perelman School of Medicine
  • Scientific Director, Diagnostic and Research Growth Center, Children's Hospital of Philadelphia

Adda Grimberg, MD is Professor of Pediatrics at the Perelman School of Medicine, University of Pennsylvania, and Scientific Director of the Diagnostic and Research Growth Center at the Children’s Hospital of Philadelphia. She received her undergraduate and medical education at Cornell University, and completed both her residency in Pediatrics and fellowship in Pediatric Endocrinology at the Children’s Hospital of Philadelphia. She was subsequently appointed to the faculty in the same institution in the Division of Pediatric Endocrinology and Diabetes. Trained as a translational physician scientist, Dr. Grimberg’s research focuses on the growth hormone (GH)/insulin-like growth factor (IGF) axis and clinical issues related to child growth. One of her principal research areas involves describing, understanding and addressing disparities in the evaluation and management of growth faltering. She is interested in GH as an illustrative pipeline issue – how the advent of an expensive therapeutic transformed a fundamental aspect of pediatric health care from its medical focus into socially driven health care consumerism. Dr. Grimberg has published over 130 scientific articles, reviews and textbook chapters. Her research has been recognized with numerous awards, including the Pediatric Endocrine Society Genentech Clinical Scholar Award, and with coverage in multiple media venues in the United States and abroad, including the New York Times. Dr. Grimberg chaired the taskforce charged with drafting the new guidelines for GH and IGF-I use in children and adolescents for the Pediatric Endocrine Society, served on the Federal Advisory Committee for the National Children’s Study of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, was elected to the Council of the Growth Hormone Research Society, and has been an invited participant in multiple consensus workshops related to GH treatment on behalf of the Pediatric Endocrine Society, the Growth Hormone Research Society, and the Endocrine Society.

Related Content